Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positron emitting activity is a diagnostic molecular imaging technique that uses positron emission tomography (PET) to visualize and measure metabolic or biochemical functions in tissues and organs. It involves injecting a radiotracer that emits positrons, which are detected to create images reflecting tracer concentration and activity. Common applications include cancer diagnosis and staging, neurological disorder assessment, and cardiovascular function evaluation.
Detection via PET after administration of positron-emitting radiopharmaceuticals. The radiotracers target specific biological processes or molecules, and the emitted positrons are detected to create images reflecting tracer concentration and activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positron Emitting Activity (Diagnostic).